Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
113.8 SEK | -0.91% | +0.35% | -10.54% |
Evolution of the average Target Price on Calliditas Therapeutics AB
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Calliditas Therapeutics AB
Guggenheim | |
HC Wainwright | |
Citigroup |
EPS Revisions
- Stock
- Equities
- Stock Calliditas Therapeutics AB - Nasdaq Stockholm
- Consensus Calliditas Therapeutics AB